RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+17.79%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$337M
AUM Growth
+$337M
(+52%)
Cap. Flow
+$79.6M
Cap. Flow
% of AUM
23.61%
Top 10 Holdings %
Top 10 Hldgs %
71.41%
Holding
42
New
16
Increased
6
Reduced
4
Closed
8
Top Buys
| 1 |
Incyte
INCY
|
$20.3M |
| 2 |
AGEN
Agenus
AGEN
|
$17.7M |
| 3 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$13.9M |
| 4 |
Celldex Therapeutics
CLDX
|
$11.9M |
| 5 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$7.91M |
Top Sells
| 1 |
DYAX
DYAX CORPORATION
DYAX
|
$27.2M |
| 2 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$19.1M |
| 3 |
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
|
$3M |
| 4 |
Assembly Biosciences
ASMB
|
$2.7M |
| 5 |
Adverum Biotechnologies
ADVM
|
$2.08M |
Sector Composition
| 1 | Healthcare | 72.97% |
| 2 | Financials | 0% |
| 3 | Consumer Discretionary | 0% |
